Stock Price Forecast

April 23, 2024


Forecasted Returns

7 Days Predict

30 Days Predict

90 Days Predict


Forecasted Market-Excess Returns

7 Days Predict

30 Days Predict

90 Days Predict

Loading bluebird bio, Inc. chart...

About the Company

We do not have any company description for bluebird bio, Inc. at the moment.

Exchange

Nasdaq

$21M

Total Revenue

733

Employees

$104M

Market Capitalization

-0.61

Price/Earning ratio

Fundamental Data and Insider Transactions (Quarterly data) Full Screen

Loading the fundamentals chart...

Latest $BLUE News

Lost Money on bluebird bio, Inc. (BLUE)? Join Class Action Suit Seeking Recovery – Contact Levi & Korsinsky

8h ago, source:

NEW YORK, NY / ACCESSWIRE / April 24, 2024 / If you suffered a loss on your bluebird bio, Inc. (NASDAQ:BLUE) investment and want to learn about a ...

BLUE Equity Alert: ROSEN, A Top Ranked Law Firm, Encourages bluebird bio Inc. Investors to Inquire About Securities Class Action Investigation - BLUE

8h ago, source:

ROSEN, A Top Ranked Law Firm, Encourages bluebird bio Inc. Investors to Inquire About Securities Class Action Investigation - BLUE ...

INVESTOR ACTION NOTICE: The Schall Law Firm Encourages Investors in bluebird bio, Inc. with ...

1d ago, source: The Bakersfield Californian

LOS ANGELES, April 24, 2024 (GLOBE NEWSWIRE) -- The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against bluebird bio, Inc. (“bluebird” ...

bluebird bio, Inc. (NASDAQ:BLUE) Q4 2023 Earnings Call Transcript

22d ago, source: InvestingChannel on MSN

bluebird bio, Inc. isn't one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details ...

bluebird bio, Inc. (BLUE)

6d ago, source: Yahoo Finance

SOMERVILLE, Mass., April 11, 2024--bluebird bio, Inc. (Nasdaq: BLUE) today announced that the Compensation Committee of the Company’s Board of Directors approved inducement grants of 102,700 ...

bluebird bio Reports Fourth Quarter and 2023 Annual Results and Highlights Operational Progress and 2024 Guidance

1mon ago, source: Morningstar

bluebird bio, Inc. (NASDAQ: BLUE) (“bluebird bio” or the “Company”) today reported fourth quarter and annual financial results and business highlights for the year ended December 31 ...

Q4 2023 bluebird bio Inc Earnings Call

29d ago, source: Yahoo Finance

Andrew Obenshain; President, Chief Executive Officer, Director; bluebird bio Inc Tom Klima; Chief Commercial Officer, Chief Operating Officer; bluebird bio Inc Chris Krawtschuk; Chief Financial ...

Bluebird bio Inc

3d ago, source: U.S. News & World Report

For most investors, the best investment strategy is to buy good stocks and hold them for the long run.

bluebird bio Inc BLUE

3d ago, source: Morningstar

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Latest Neutral (free) Forecasts

STRONG BUY BUY NEUTRAL SELL STRONG SELL ALL

Loading the latest forecasts...

My Portfolio

Loading your portfolio...